's Biography

, ,

Dr. Allan Wu is an Aesthetic Reconstructive Cosmetic Surgeon with formal fellowship background training in Surgical Molecular and Cellular Biology from UCLA and Molecular Embryology from the Bourn Hall Clinic in Cambridge U.K. (home of the world’s first “test tube baby”). He is also a board certified tissue banking specialist and cryobiologist. He has worked extensively with the American Association of Tissue Banks in formulating early recommendations for proper tissue banking of adult mesenchymal stem cells. He is currently tenured as director of Women’s Health and Surgery, Regenerative Medicine and Chief Scientific Officer at The Morrow Institute.

ADSC: Lowest Lying Fruit or Lowest Shelved Pandora’s Box? Negotiating a safe, legal and ethical pathway for ADSC use in the United States

Monday, 22 April 2013 at 09:00

Add to Calendar ▼2013-04-22 17:00:002013-04-22 18:00:00Europe/LondonClinical Practicum: Delegate Viewing of Reconstructive Surgery ProceduresClinical Translation of Stem Cells Summit in Palm Springs, CA, USAPalm Springs, CA, USASELECTBIOenquiries@selectbiosciences.com

Although the regulatory environment for adipose adult mesenchymal stem cells is still in a phase of “ripeness”, some general guidelines for clinicians have finally come into focus. For example, following the recent US District Court ruling of Regenexx vs. the FDA, it is clear that any cell culture for immediate autologous use is considered beyond the scope of minimal manipulation. Furthermore, formal inquiries to the FDA that have come into the public domain indicate some forms of cell assisted lipotransfer (CAL) may also be deemed beyond minimal manipulation. Still questions remain. What is allowable and what is considered safe and within standard of care and how can a practitioner continue to operate given the recent regulatory climate? A suggested best practice method will be presented during this lecture to help clinicians negotiate a safe, legal and ethical pathway for practice within the United States. A detailed discussion of 21 CFR 1271 and potential scientific remedies to address safety, efficacy and minimal manipulation documentation will also be provided.

Clinical Practicum: Delegate Viewing of Reconstructive Surgery Procedures

Monday, 22 April 2013 at 17:00

Add to Calendar ▼2013-04-22 00:00:002013-04-23 00:00:00Europe/LondonClinical Translation of Stem Cells SummitClinical Translation of Stem Cells Summit in Palm Springs, CA, USAPalm Springs, CA, USASELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors